Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

NCI Dictionary of Cancer Terms

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Dictionary of Cancer Terms features 8,214 terms related to cancer and medicine.

We offer a widget that you can add to your website to let users look up cancer-related terms. Get NCI’s Dictionary of Cancer Terms Widget.

Browse:
interleukin-1-alpha
(in-ter-LOO-kin … AL-fuh)
One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. Interleukin-1-alpha, one form of interleukin-1, is made mainly by one type of white blood cell, the macrophage, and helps another type of white blood cell, the lymphocyte, fight infections. It also helps leukocytes pass through blood vessel walls to sites of infection and causes fever by affecting areas of the brain that control body temperature. The other form of interleukin-1, interleukin-1-beta, acts the same as interleukin-1-alpha. Interleukin-1-alpha made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. Interleukin-1-alpha is a type of cytokine. Also called IL-1-alfa, IL-1-alpha, and interleukin-1-alfa.